Eye Stroke Explained: CRAO vs. BRVO — What Patients Need to Know

Imagine waking up one morning and noticing that vision in one eye is suddenly blurred, dark, or partially missing. There’s no pain, no warning, just an immediate sense that something is very wrong. Many people assume this must be a problem with glasses or fatigue, but in some cases, it’s something far more serious: an eye stroke. Just like a stroke in the brain, an eye stroke happens when blood flow is disrupted, and the consequences can be permanent if not treated quickly. Two of the most commonly confused types are Central Retinal Artery Occlusion (CRAO) and Branch Retinal Vein Occlusion (BRVO). While they sound similar, they behave very differently, and understanding the difference can be vision-saving.

Understanding Eye Strokes: This infographic explains the differences between Central Retinal Artery Occlusion (CRAO) and Branch Retinal Vein Occlusion (BRVO), highlighting the urgency and symptoms associated with each to emphasize the eye's role as a health warning system.

An eye stroke refers to a sudden blockage of blood flow to the retina, the delicate layer of nerve tissue at the back of the eye responsible for turning light into visual signals. The retina is one of the most metabolically active tissues in the body, meaning it depends on a constant, uninterrupted blood supply. Even brief interruptions can lead to lasting damage. The key difference between CRAO and BRVO lies in whether an artery or a vein is affected, and that distinction shapes everything from symptoms to urgency to long-term outlook (Eye Stroke CRAO vs BRVO).

CRAO is often described as the “heart attack of the eye.” It occurs when the central retinal artery, the main vessel supplying oxygen-rich blood to the retina, becomes suddenly blocked. This blockage is usually caused by a clot or cholesterol plaque that travels from elsewhere in the body, often from the carotid arteries or the heart. Patients typically experience a sudden, profound loss of vision in one eye that is painless and immediate. Vision may drop to the point where only light or motion can be detected. Because retinal nerve cells are extremely sensitive to oxygen deprivation, damage can begin within minutes. This is why CRAO is considered a true medical emergency, not just an eye problem but a warning sign of serious underlying vascular disease.

BRVO, on the other hand, involves a blockage in one of the smaller retinal veins rather than the main artery. Veins are responsible for draining blood away from the retina, and when one becomes compressed or blocked, blood and fluid back up into the surrounding retinal tissue. This backup leads to swelling, hemorrhages, and sometimes leakage that affects vision. Vision loss in BRVO is often partial rather than complete and may develop over hours or days instead of instantly. Some patients notice distortion, a dark spot, or blurred vision in a specific area of their visual field rather than the entire eye. While BRVO is still serious and requires prompt evaluation, it is usually not as immediately catastrophic as CRAO.

One of the most important differences between these two conditions is urgency. CRAO should be treated as an emergency similar to a brain stroke. Patients with suspected CRAO are often referred immediately to the emergency department because the condition is closely linked to an increased risk of stroke and heart attack. A thorough systemic workup is critical to identify the source of the blockage and prevent future life-threatening events. Even though treatments to restore vision after CRAO are limited and time-sensitive, rapid diagnosis can still play a crucial role in protecting overall health.

BRVO, while not typically a medical emergency in the same way, still requires timely care from a retina specialist. Treatment focuses on managing complications such as macular edema, which is swelling in the central retina that causes blurred vision. Modern therapies, including anti-VEGF injections and, in some cases, laser treatment, have significantly improved visual outcomes for many patients. Just as importantly, BRVO often signals underlying health issues such as high blood pressure, diabetes, or elevated cholesterol, and addressing these factors is essential to prevent recurrence or involvement of the other eye.

Early diagnosis matters tremendously for both conditions. Subtle differences in symptoms can be misleading, and many patients delay seeking care because there is no pain. Advanced retinal imaging allows specialists to quickly distinguish between arterial and venous occlusions and to assess the extent of retinal damage. This distinction guides not only eye treatment but also the urgency of systemic evaluation. In many cases, an eye stroke is the first visible sign of a much larger vascular problem, making the eye a window into overall health.

If there is one takeaway patients should remember, it is this: sudden vision changes in one eye are never normal and should never be ignored. Whether the cause is CRAO or BRVO, time matters. Prompt evaluation can mean the difference between stabilizing vision, preventing further loss, and uncovering serious health risks before they become life-threatening. The eye often tells a story that the rest of the body has not yet revealed, and listening early can change outcomes dramatically.

At South Bay Retina, we believe patient education and early detection go hand in hand. Understanding conditions like CRAO and BRVO empowers patients to act quickly, ask the right questions, and take control of both their vision and their overall health. If you or someone you love experiences sudden changes in vision, it’s not something to wait out. It’s a reason to be seen, urgently and expertly.

Connect with Us

Website: www.southbayretina.com

Phone: (408) 294-3534

Serving: San Jose, Cupertino, and the greater South Bay Area

YouTube: youtube.com/@NarainEye

Instagram: @south_bay_retina

Facebook: @narain1

TikTok: @southbayretina

Podbean: southbayretinamedia.podbean.com

References

1. Hayreh, S. S. (2011). Management of central retinal artery occlusion. Ophthalmologica, 226(4), 175–183. https://pubmed.ncbi.nlm.nih.gov/21912102/

2. Varma, D. D., Cugati, S., Lee, A. W., & Chen, C. S. (2013). A review of central retinal artery occlusion: Clinical presentation and management. Eye, 27(6), 688–697. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682349/

3. Rogers, S., McIntosh, R. L., Cheung, N., et al. (2010). The prevalence of retinal vein occlusion: Pooled data from population studies. Ophthalmology, 117(2), 313–319. https://pubmed.ncbi.nlm.nih.gov/20022117/

4. American Academy of Ophthalmology. (2023). Retinal vein occlusion and retinal artery occlusion. https://www.aao.org/eye-health/diseases

WATCH THE FULL EPISODE'S HERE:

LISTEN TO THE PODCAST EPISODES: